Indications
Treatment of respiratory dysfunction in patients with Duchenne muscular dystrophy (DMD) not using glucocorticoids
Composition
- Active substance
- idebenone, titanium dioxide
- International name (INN)
- idebenone
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Puldysa
- Active substance
- idebenone, titanium dioxide
- ATC code
- N06BX13
- Group
- Nervous system
- Therapeutic area
- Muscular Dystrophy, Duchenne
- Marketing authorisation holder
- Santhera Pharmaceuticals (Deutschland) GmbH
- Status
- Application withdrawn